The real-world data in patients with advanced gastric cancer treated with ramucirumab combination chemotherapy.

被引:2
|
作者
Kimura, Akie
Sakai, Daisuke
Kudo, Toshihiro
Nishida, Naohiro
Katou, Aya
Inagaki, Chiaki
Otsuru, Toru
Tanaka, Koji
Miyazaki, Yasuhiro
Makino, Tomoki
Takahashi, Tsuyoshi
Kurokawa, Yukinori
Yamasaki, Makoto
Doki, Yuichiro
Mori, Masaki
Satoh, Taroh
机构
[1] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan
[2] Osaka Univ, Dept Gastroenterol Surg, Grad Sch Med, Suita, Osaka, Japan
关键词
D O I
10.1200/JCO.2019.37.4_suppl.156
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
156
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Real-world outcomes of patients with advanced gastric cancer treated with FOLFIRI.
    Fawaz, Ali
    Tilley, Derek
    Karachiwala, Hatim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 307 - 307
  • [2] Prognostic factors for survival in patients with advanced gastric cancer treated with chemotherapy.
    Mangas, Montserrat
    Carmona Bayonas, Alberto
    Sanchez Lorenzo, Maria Luisa
    Ramchandani, Avinash
    Garcia, Teresa
    Custodio, Ana B.
    Lorenzo Barreto, Jose Enrique
    Diaz Guardamino, Isabel Echavarria
    Diaz Serrano, Asuncion
    Maria Cano, Juana
    Azkarate, Aitor
    Longo, Federico
    Mugica, Maitane
    Sanchez, Rodrigo
    Serrano, Raquel
    Alvarez Mancenido, Felipe Jose
    Alsina, Maria
    Jimenez-Fonseca, Paula
    Garrido, Marcelo
    Gallego Plazas, Javier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [3] Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer - clinical trials and real-world data
    Knetki-Wroblewska, Magdalena
    Kowalski, Dariusz M.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (03): : 209 - 214
  • [4] Real-world outcomes of patients with advanced non-small cell lung cancer and driver mutations treated with frontline immunotherapy and/or chemotherapy.
    Muthusamy, Bharathi
    Pennell, Nathan A.
    Belli, Andrew J.
    Hansen, Eric
    Devincenzo, Victoria
    Shankaranarayana, Shubha
    He, Ming
    Wang, Ching-Kun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Real-world delivery rate to third-line chemotherapy in patients with advanced gastric cancer
    Ueno, Masayuki
    Doi, Akira
    Mouri, Hirokazu
    Yamamoto, Hiroshi
    Mizuno, Motowo
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] The impact of the extent of gastric resection on advanced gastric cancer treated with systemic chemotherapy.
    Sasaki, Yusuke
    Watanabe, Yutaka
    Ohkita, Ichiro
    Hirota, Jojo
    Konno, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Real-world antiemetic utilization in patients undergoing carboplatin chemotherapy.
    Polson, Michael
    Harrow, Brooke
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [8] Real-world ramucirumab and immune checkpoint inhibitor sequences in US patients with advanced gastroesophageal cancer
    Liepa, Astra M.
    Cui, Zhanglin Lin
    Beyrer, Julie K.
    Hadden, Elizabeth L.
    Chatterjee, Anindya
    [J]. FUTURE ONCOLOGY, 2023, 19 (18) : 1277 - 1291
  • [9] Real-world comparison of biosimilar filgrastim and reference filgrastim in cancer patients receiving chemotherapy.
    Chen, Xiaoxue
    Barron, John
    Agiro, Abiy
    Debono, David Joseph
    Fisch, Michael Jordan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [10] Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer A Real-world Study
    Abdel-Rahman, Omar
    Mulder, Karen
    Easaw, Jacob
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (04): : 158 - 161